Having trouble accessing articles? Reset your cache.

Vectura up on formulation deal with GSK

Vectura Group plc (LSE:VEC) rose 6.5p (13%) to 55p on Friday

Read the full 114 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE